An Overview of Lung Cancer in Women and the Impact of Estrogen in Lung Carcinogenesis and Lung Cancer Treatment

Overview

Journal Front Med (Lausanne)

Specialty General Medicine

Date 2021 Jun 3

PMID 34079807

Citations 18

Authors

Vianey Rodriguez-Lara

Maria Rosa Avila-Costa

Affiliations

Soon will be listed here.

Abstract

Lung cancer incidence and mortality have significantly increased in women worldwide. Lung adenocarcinoma is the most common form of lung cancer globally. This type of lung cancer shows differences by sex, including the mutational burden, behavior, clinical characteristics, and response to treatment. The effect of sex on lung cancer patients' survival is still controversial; however, lung adenocarcinoma is considered a different disease in women and men. Moreover, lung adenocarcinoma is strongly influenced by estrogen and is also different depending on the hormonal status of the patient. Young pre-menopausal women have been explored as an independent group. They presented in more advanced stages at diagnosis, exhibited more aggressive tumors, and showed poor survival compared to men and post-menopausal women, supporting the role of sex hormones in this pathology. Several reports indicate the estrogen's role in lung carcinogenesis and tumor progression. Thus, there are currently some clinical trials testing the efficacy of antihormonal therapy in lung cancer treatment. This mini review shows the updated data about lung cancer in women, its characteristics, the etiological factors that influence carcinogenesis, and the critical role of estrogen in lung cancer and treatment.

Citing Articles

Sex Disparity in Cancer: Role of Autophagy and Estrogen Receptors.

Vona R, Cittadini C, Ortona E, Matarrese P Cells. 2025; 14(4).

PMID: 39996745 PMC: 11854201. DOI: 10.3390/cells14040273.

Maternal nutrition and offspring lung health: sex-specific pathway modulation in fibrosis, metabolism, and immunity.

Zhao S, Chen Z, Liu H, Wang X, Zhang X, Shi H Food Nutr Res. 2025; 69.

PMID: 39790857 PMC: 11708518. DOI: 10.29219/fnr.v69.11035.

Lung cancer and obesity: A contentious relationship (Review).

Georgakopoulou V, Lempesis I, Trakas N, Sklapani P, He Y, Spandidos D Oncol Rep. 2024; 52(5).

PMID: 39497438 PMC: 11462394. DOI: 10.3892/or.2024.8817.

Analysis of Modular Hub Genes and Therapeutic Targets across Stages of Non-Small Cell Lung Cancer Transcriptome.

Barretto A, Orda M, Tsai P, Tayo L Genes (Basel). 2024; 15(10).

PMID: 39457373 PMC: 11507033. DOI: 10.3390/genes15101248.

NUSAP1 is Upregulated by Estrogen to Promote Lung Adenocarcinoma Growth and Serves as a Therapeutic Target.

Zhang S, Zhang X, Huang W, Jiang G, Mo Y, Wei L Int J Biol Sci. 2024; 20(13):5375-5395.

PMID: 39430250 PMC: 11489181. DOI: 10.7150/ijbs.100188.

References

Giannopoulou E, Siatis K, Metsiou D, Kritikou I, Papachristou D, Kalofonou M . The inhibition of aromatase alters the mechanical and rheological properties of non-small-cell lung cancer cell lines affecting cell migration. Biochim Biophys Acta. 2014; 1853(2):328-37. DOI: 10.1016/j.bbamcr.2014.11.016. View

Rodriguez-Lara V, Ramirez-Tirado L, Barron F, Zatarain-Barron Z, Flores-Estrada D, Arrieta O . Characteristics of non-small cell lung cancer: differences by sex and hormonal status in a Mexican population. Salud Publica Mex. 2019; 61(3):265-275. DOI: 10.21149/10094. View

Nagy-Mignotte H, Guillem P, Vesin A, Toffart A, Colonna M, Bonneterre V . Primary lung adenocarcinoma: characteristics by smoking habit and sex. Eur Respir J. 2011; 38(6):1412-9. DOI: 10.1183/09031936.00191710. View

Xu R, Shen H, Guo R, Sun J, Gao W, Shu Y . Combine therapy of gefitinib and fulvestrant enhances antitumor effects on NSCLC cell lines with acquired resistance to gefitinib. Biomed Pharmacother. 2012; 66(5):384-9. DOI: 10.1016/j.biopha.2012.02.004. View

Mollerup S, Jorgensen K, Berge G, Haugen A . Expression of estrogen receptors alpha and beta in human lung tissue and cell lines. Lung Cancer. 2002; 37(2):153-9. DOI: 10.1016/s0169-5002(02)00039-9. View

Radkiewicz C, Dickman P, Johansson A, Wagenius G, Edgren G, Lambe M . Sex and survival in non-small cell lung cancer: A nationwide cohort study. PLoS One. 2019; 14(6):e0219206. PMC: 6597110. DOI: 10.1371/journal.pone.0219206. View

Hershberger P, Vasquez A, Kanterewicz B, Land S, Siegfried J, Nichols M . Regulation of endogenous gene expression in human non-small cell lung cancer cells by estrogen receptor ligands. Cancer Res. 2005; 65(4):1598-605. DOI: 10.1158/0008-5472.CAN-04-2694. View

Zhang K, Chen H, Chen Y, Qiu K, Zheng X, Li G . Bisphenol A stimulates human lung cancer cell migration via upregulation of matrix metalloproteinases by GPER/EGFR/ERK1/2 signal pathway. Biomed Pharmacother. 2014; 68(8):1037-43. DOI: 10.1016/j.biopha.2014.09.003. View

Malvezzi M, Carioli G, Bertuccio P, Boffetta P, Levi F, La Vecchia C . European cancer mortality predictions for the year 2017, with focus on lung cancer. Ann Oncol. 2017; 28(5):1117-1123. DOI: 10.1093/annonc/mdx033. View

10.

Hamilton D, Griner L, Keller J, Hu X, Southall N, Marugan J . Targeting Estrogen Receptor Signaling with Fulvestrant Enhances Immune and Chemotherapy-Mediated Cytotoxicity of Human Lung Cancer. Clin Cancer Res. 2016; 22(24):6204-6216. PMC: 5143224. DOI: 10.1158/1078-0432.CCR-15-3059. View

11.

Bethune G, Bethune D, Ridgway N, Xu Z . Epidermal growth factor receptor (EGFR) in lung cancer: an overview and update. J Thorac Dis. 2012; 2(1):48-51. PMC: 3256436. View

12.

Chlebowski R, Wakelee H, Pettinger M, Rohan T, Liu J, Simon M . Estrogen Plus Progestin and Lung Cancer: Follow-up of the Women's Health Initiative Randomized Trial. Clin Lung Cancer. 2015; 17(1):10-7.e1. PMC: 6855180. DOI: 10.1016/j.cllc.2015.09.004. View

13.

Rodriguez-Lara V, Ignacio G, Cerbon Cervantes M . Estrogen induces CXCR4 overexpression and CXCR4/CXL12 pathway activation in lung adenocarcinoma cells in vitro. Endocr Res. 2017; 42(3):219-231. DOI: 10.1080/07435800.2017.1292526. View

14.

Srinivasan M, Taioli E, Ragin C . Human papillomavirus type 16 and 18 in primary lung cancers--a meta-analysis. Carcinogenesis. 2009; 30(10):1722-8. PMC: 2764507. DOI: 10.1093/carcin/bgp177. View

15.

Chiu H, Cheng M, Tsai S, Wu T, Kuo H, Yang C . Outdoor air pollution and female lung cancer in Taiwan. Inhal Toxicol. 2006; 18(13):1025-31. DOI: 10.1080/08958370600904561. View

16.

Tam A, Morrish D, Wadsworth S, Dorscheid D, Paul Man S, Sin D . The role of female hormones on lung function in chronic lung diseases. BMC Womens Health. 2011; 11:24. PMC: 3129308. DOI: 10.1186/1472-6874-11-24. View

17.

Marquez-Garban D, Mah V, Alavi M, Maresh E, Chen H, Bagryanova L . Progesterone and estrogen receptor expression and activity in human non-small cell lung cancer. Steroids. 2011; 76(9):910-20. PMC: 3129425. DOI: 10.1016/j.steroids.2011.04.015. View

18.

Li Z, Wang Y, Shen Y, Qian C, Oupicky D, Sun M . Targeting pulmonary tumor microenvironment with CXCR4-inhibiting nanocomplex to enhance anti-PD-L1 immunotherapy. Sci Adv. 2020; 6(20):eaaz9240. PMC: 7228744. DOI: 10.1126/sciadv.aaz9240. View

19.

Freitas A, Gurgel A, de Lima E, Sao Marcos B, do Amaral C . Human papillomavirus and lung cancinogenesis: an overview. J Cancer Res Clin Oncol. 2016; 142(12):2415-2427. DOI: 10.1007/s00432-016-2197-1. View

20.

Ganti A, Sahmoun A, Panwalkar A, Tendulkar K, Potti A . Hormone replacement therapy is associated with decreased survival in women with lung cancer. J Clin Oncol. 2005; 24(1):59-63. DOI: 10.1200/JCO.2005.02.9827. View